DrugRepV Browse Page

DrugRepV browse page allows user to take a glance of the particular antiviral agent.Fields in the webpage is hylerlinked ot various external repositories like DrugBank, PubChem, Clinicaltrials.gov,and PubMed.User can explore the biological, Clinical, Chemical, and Structural details of every repurposed drug candidate.By clicking on the table header arrows, user can sort entries in ascending or descending order.


Total number of Records for Antibacterial are 52

DrugRepV_ID	Antiviral Name	Drug type	Primary Indication	Secondary Indication	Strain	Pathways	Assay	Activity	Clinical Status	References
DrugRepV_0243	D-LANA-14	Antibacterial	Bacterial infections	Ebola virus	ME718-1976/Yambuku-Ecran	NA	Real-time PCR	Decrease (>10 Ct)	NA	27801778
DrugRepV_0244	D-LANA-14	Antibacterial	Bacterial infections	Ebola virus	ME718-1976/Yambuku-Ecran	NA	Real-time PCR	Decrease (>10 Ct)	NA	27801778
DrugRepV_0258	D-LANA-14	Antibacterial	Bacterial infections	Ebola virus	ME718-1976/Yambuku-Ecran	NA	Real-time PCR	Decrease (0.96 ± 0.19 Ct)	NA	27801778
DrugRepV_1089	Ceftazidime	Antibacterial	Bacterial infections	Zika virus	MEX_I_7	NA	Fluorescence-based assay	Decrease (53.255 %)	Approved	27476412
DrugRepV_1419	Clavulanate Potassium	Antibacterial	Bacterial infections	Zika virus	MEX_I_7	NA	Fluorescence-based assay	Decrease (47.97 %)	Approved	27476412
DrugRepV_1712	Malachite green oxalate	Antibacterial	NA	Zika virus	MR766	NA	Cell viability assay	No significant effect (0 %)	Experimental	27571349
DrugRepV_1783	Malachite green oxalate	Antibacterial	NA	Zika virus	MR766	NA	Cell viability assay	No significant effect (0 %)	Experimental	27571349
DrugRepV_1854	Malachite green oxalate	Antibacterial	NA	Zika virus	MR766	NA	Cell viability assay	No significant effect	Experimental	27571349
DrugRepV_1976	Anisomycin	Antibacterial	Bacterial infections	Middle East respiratory syndrome coronavirus	Jordan	NA	Enzyme-linked immunosorbent assay	Decrease (50 %)	Experimental	24841273
DrugRepV_1977	Cycloheximide	Antibacterial	Bacterial and fungal infections	Middle East respiratory syndrome coronavirus	Jordan	NA	Enzyme-linked immunosorbent assay	Decrease (50 %)	NA	24841273
DrugRepV_2001	Anisomycin	Antibacterial	Bacterial infections	Severe acute respiratory syndrome coronavirus	NA	NA	Cytopathic effect (CPE) assay	Decrease (50 %)	Experimental	24841273
DrugRepV_2002	Cycloheximide	Antibacterial	Bacterial and fungal infections	Severe acute respiratory syndrome coronavirus	NA	NA	Cytopathic effect (CPE) assay	Decrease (50 %)	NA	24841273
DrugRepV_2434	Sarafloxacin Hydrochloride	Antibacterial	NA	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	No significant decrease (1.52020966 %)	Vet approved, Withdrawn	27742486
DrugRepV_2440	Racecadotril	Antibacterial	Diarrhea | Acute Diarrhea | Acute Gastroenteritis	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	No significant decrease (1.33496745 %)	Investigational	27742486
DrugRepV_2632	Balofloxacin	Antibacterial	Bacterial infection	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-1.9028632 %)	Approved	27742486
DrugRepV_2739	Hygromycin B	Antibacterial	Bacterial infections	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-3.6080755 %)	Vet approved	27742486
DrugRepV_2765	Tebipenem pivoxil	Antibacterial	Bacterial infections	Chikungunya virus	vAc-CHIKV 26S-Rhir-E	NA	Fusion index-Fluorescent Intensities	Increase (-4.2767522 %)	NA	27742486
DrugRepV_3090	Anisomycin	Antibacterial	Bacterial infection	Chikungunya virus	CHIKV-0708	NA	Immunoflourescence assay	Decrease (99.96 %)	Experimental	23275491
DrugRepV_3106	Cycloheximide	Antibacterial	Bacterial infections	Chikungunya virus	CHIKV-0708	NA	Immunoflourescence assay	Decrease (99.1 %)	NA	23275491
DrugRepV_3108	Narasin	Antibacterial	Parasitic and bacterial infections	Chikungunya virus	CHIKV-0708	NA	Immunoflourescence assay	Decrease (98.89 %)	Experimental	23275491
DrugRepV_5516	Narasin	Antibacterial	Parasitic and bacterial infections	Lassa virus	NA	NA	Gaussia luciferase (Gluc) Glow assay	Decrease (50 %)	Experimental	31786250
DrugRepV_5799	Geneticin	Antibacterial	Bacterial infections	Dengue virus	NA		Almar Blue assay	Decrease (50 %)	Experimental	19501253
DrugRepV_5800	Geneticin	Antibacterial	Bacterial infections	Dengue virus	NA		Real-time PCR	Decrease (90 %)	Experimental	19501253
DrugRepV_5801	Geneticin	Antibacterial	Bacterial infections	Dengue virus	NA		Western blot	Decrease (100 %)	Experimental	19501253
DrugRepV_5802	Geneticin	Antibacterial	Bacterial infections	Dengue virus	NA		Western blot	Decrease (80 %)	Experimental	19501253
DrugRepV_5808	Anisomycin	Antibacterial	Bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (82.49 %)	Experimental	22155902
DrugRepV_5810	Cycloheximide	Antibacterial	Bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (78.71 %)	NA	22155902
DrugRepV_5814	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (55.89 %)	Experimental	22155902
DrugRepV_5833	Anisomycin	Antibacterial	Bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5836	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5837	Anisomycin	Antibacterial	Bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (100 %)	Experimental	22155902
DrugRepV_5840	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (80 %)	Experimental	22155902
DrugRepV_5841	Anisomycin	Antibacterial	Bacterial infections	Dengue virus	NA		Plaque assay	Decrease (5 Logs reduction)	Experimental	22155902
DrugRepV_5844	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (5 Logs reduction)	Experimental	22155902
DrugRepV_5845	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5846	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5847	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5848	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (50 %)	Experimental	22155902
DrugRepV_5849	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	No significant effect (0 %)	Experimental	22155902
DrugRepV_5850	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease	Experimental	22155902
DrugRepV_5851	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease	Experimental	22155902
DrugRepV_5852	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	No significant effect	Experimental	22155902
DrugRepV_5853	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (3.8 Logs reduction)	Experimental	22155902
DrugRepV_5854	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Plaque assay	Decrease (5 Logs reduction)	Experimental	22155902
DrugRepV_5855	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	No significant effect (0 %)	Experimental	22155902
DrugRepV_5856	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Immunoflourescence assay	Decrease (90 %)	Experimental	22155902
DrugRepV_5857	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Real-time PCR	No significant effect (0 Copies number)	Experimental	22155902
DrugRepV_5858	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Western blot	Decrease	Experimental	22155902
DrugRepV_5859	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	NA		Western blot	Decrease	Experimental	22155902
DrugRepV_6321	Anisomycin	Antibacterial	Bacterial infection	Dengue virus	New Guinea C		Immunoflourescence assay	Decrease (82.49 %)	Experimental	22155902
DrugRepV_6323	Cycloheximide	Antibacterial	Bacterial infections	Dengue virus	New Guinea C		Immunoflourescence assay	Decrease (78.71 %)	NA	22155902
DrugRepV_6327	Narasin	Antibacterial	Parasitic and bacterial infections	Dengue virus	New Guinea C		Immunoflourescence assay	Decrease (50 %)	Experimental	22155902